Image pharmaphorum Editor AZ-roundtable-biographies-2017 Roundtable participant biography – Gunnar Brandrup-Wognsen Global Medical Affairs Leader, AstraZeneca AZ-roundtable-biographies-2017 Roundtable participant biography – Professor Christopher Gra... Professor of Medicine and Member of the Duke Clinical Research Institute, Durham, USA AZ-roundtable-debate-2017 Video roundtable – complete footage Complete roundtable video debate on secondary prevention of recurrent atherothrombotic events AZ-roundtable-debate-2017 Video roundtable – Part 1 Part 1 of the roundtable video debate on epidemiology and background of recurrent atherothrombotic events in high-risk patients Load more results
AZ-roundtable-biographies-2017 Roundtable participant biography – Gunnar Brandrup-Wognsen Global Medical Affairs Leader, AstraZeneca
AZ-roundtable-biographies-2017 Roundtable participant biography – Professor Christopher Gra... Professor of Medicine and Member of the Duke Clinical Research Institute, Durham, USA
AZ-roundtable-debate-2017 Video roundtable – complete footage Complete roundtable video debate on secondary prevention of recurrent atherothrombotic events
AZ-roundtable-debate-2017 Video roundtable – Part 1 Part 1 of the roundtable video debate on epidemiology and background of recurrent atherothrombotic events in high-risk patients
News Novo Nordisk beefs up in oral obesity drugs with Vivtex deal Novo Nordisk is leaving no stone unturned in its bid to maintain its position in weight-loss therapies as it signs a $2.1bn alliance with Vivtex.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
